2025 International Congress

October 5-9, 2025. Honolulu, Hawaii.

View by Title View Categories

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Parkinsonism in a case of Gerstmann Sträussler Scheinker disease

S. Poveda, O. Bernal-Pacheco, L. Lancheros, J. Montealegre (Bogotá, Colombia)
Parkinsonism in KMT5B-related Disorders: Expanding the Spectrum.

P. Rábano-Suárez, A. Sánchez-Ferro, A. Arteche-López, JF. Quesada, R. Pérez, M. Morales, L. Jiménez Díez-Canseco, A. Galiana, A. Méndez-Guerrero (Madrid, Spain)
Parkinsonism in Uzbekistan: Clinical and Demographic Insights from 2024

Y. Nishonova, B. Mukhammedaminov, L. Kenjaeva, N. Aripova (Tashkent, Uzbekistan)
PARKinSOUND 2.0: The Impact of Orchestra Participation on Patients with Parkinson’s Disease

S. Lopes, A. Ferreira, S. Gomes, C. Morgado, L. Costa, A. Goios, J. Ferreira, M. Rodrigues (Braga, Portugal)
Paroxysmal Nonkinesigenic Dyskinesia in GLUT1 Deficiency Syndrome: A Rare Manifestation

A. Medhus, E. Krause (Austin, USA)
Paroxysmal Post-Traumatic Dystonia in Patients with Whiplash and Mild Traumatic Brain Injuries

H. Peltonen, R. Ortiz, J. Honkaniemi (Tampere, Finland)
Pathogenic TBK1 Mutation Associated with Multiple System Atrophy-Like Phenotype

S. Barton, C. Siskind, H. Zahed (Palo Alto, USA)
Pathology Meets Clinical Practice: Unveiling the Pathological Evidence of Clinical Signs in Multiple System Atrophy

E. Zhunusova, P. Panyakaew, C. Shambetova, R. Bhidayasiri (Bishkek, Kyrgyzstan)
Patient And Clinician Perceptions Of Disease Improvement With Levodopa–Entacapone–Carbidopa Intestinal Gel (LECIG) In Advanced Parkinson’s – Data From The ELEGANCE Interim Analysis

N. Smith, B. Amlani (Reading, United Kingdom)
Patient engagement in Parkinson’s research: Exploring stakeholder perspectives

J. Bek, N. Simonian, C. Rattan, A. Asis (Dublin, Ireland)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z